← FDA DRUG APPROVALS

FDA ANDA · ANDA076087

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%

Sponsor: HIKMA

APPLICATION
ANDA076087
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-29
LATEST ACTION
2020-11-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Prescription
FLUCONAZOLE 400MG/200ML (2MG/ML) · INJECTABLE · INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Prescription
FLUCONAZOLE 200MG/100ML (2MG/ML) · INJECTABLE · INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Prescription
FLUCONAZOLE 100MG/50ML (2MG/ML) · INJECTABLE · INJECTION

Approval history

2020-11-27Labeling · Supplement 15 · standardAP
2020-11-27Labeling · Supplement 16 · standardAP
2012-03-14Labeling · Supplement 13AP
2012-01-30Labeling · Supplement 10AP
2012-01-30Labeling · Supplement 8AP
2008-12-01Labeling · Supplement 6AP
2008-09-26Labeling · Supplement 4AP
2004-07-29OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →